{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:07:09Z","timestamp":1775707629834,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study is to present the current care situation of patients with giant cell arteritis (GCA), Takayasu arteritis (TAK), ANCA-associated vasculitis (AAV) and Beh\u00e7et\u2019s disease (BD). Trends over the last 15\u00a0years will reflect improvements and remaining deficits in the management of vasculitides. Consecutive cross-sectional data from patients with vasculitides from the German National Database (NDB) of the Collaborative Arthritis Centres between 2007 and 2021 were included. Medication, physician- and patient-reported outcomes on disease activity and disease burden, inpatient stays and occupational participation are compared for different vasculitis entities and over time. Employment rates were compared to German population rates. Between 502 and 854 vasculitis patients were annually documented. GCA and AAV were the most common vasculitides. Median disease duration ranged from 2 to 16\u00a0years. Over the years, glucocorticoids decreased in proportion and dose, most markedly in GCA and TAK, while biologic therapies increased up to 27%. Physicians rated disease activity as low for the vast majority of patients, while patients-reported moderate outcomes in many dimensions. PROs remained largely unchanged. The proportion of employed patients (&lt;\u200965\u00a0years) increased from 47 to 57%. In recent years, biologics are increasingly used in patients with vasculitides, while glucocorticoids decreased significantly. PRO\u2019s have not improved. Work participation increased but remains lower than that in the German population.<\/jats:p>","DOI":"10.1007\/s00296-023-05508-x","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T07:02:41Z","timestamp":1704438161000},"page":"497-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Beh\u00e7et\u2019s disease: cross-sectional data of the German National Database 2007\u20132021"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-6861","authenticated-orcid":false,"given":"J\u00f6rg","family":"Henes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-3243","authenticated-orcid":false,"given":"Jutta G.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1655-0595","authenticated-orcid":false,"given":"Katja","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-4497","authenticated-orcid":false,"given":"Uta","family":"Kiltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-2728","authenticated-orcid":false,"given":"Johanna","family":"Callhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-0294","authenticated-orcid":false,"given":"Katinka","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"1","key":"5508_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5508_CR2","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA, Group DS (2022) 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81(12):1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5508_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/ard-2022-223482","volume":"81","author":"PC Grayson","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA, Group DS (2022) 2022 American College of Rheumatology\/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis 81(12):1654\u20131660. https:\/\/doi.org\/10.1136\/ard-2022-223482","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5508_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/art.41982","volume":"74","author":"PC Grayson","year":"2022","unstructured":"Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, Khalid S, Hutchings A, Luqmani RA, Watts RA, Merkel PA, Group DS (2022) 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol 74(3):386\u2013392. https:\/\/doi.org\/10.1002\/art.41982","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"5508_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","volume":"81","author":"JC Robson","year":"2022","unstructured":"Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA, Investigators D (2022) 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81(3):315\u2013320. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221795","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5508_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","volume":"81","author":"R Suppiah","year":"2022","unstructured":"Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, Judge A, Hutchings A, Merkel PA, Luqmani RA, Watts RA, Dcvas I (2022) 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 81(3):321\u2013326. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221796","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5508_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41584-023-00933-5","volume":"19","author":"G Emmi","year":"2023","unstructured":"Emmi G, Vaglio A (2023) The new look of classification criteria for systemic vasculitis. Nat Rev Rheumatol 19(4):198\u2013199. https:\/\/doi.org\/10.1038\/s41584-023-00933-5","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"5508_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","volume":"50","author":"A Sharma","year":"2020","unstructured":"Sharma A, Mohammad AJ, Turesson C (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum 50(5):1040\u20131048. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"5508_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092573","author":"R Redondo-Rodriguez","year":"2022","unstructured":"Redondo-Rodriguez R, Mena-Vazquez N, Cabezas-Lucena AM, Manrique-Arija S, Mucientes A, Fernandez-Nebro A (2022) Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11092573","journal-title":"J Clin Med"},{"issue":"5","key":"5508_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","volume":"53","author":"K Herlyn","year":"2014","unstructured":"Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford) 53(5):882\u2013889. https:\/\/doi.org\/10.1093\/rheumatology\/ket440","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"5508_CR11","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1093\/rheumatology\/keaa924","volume":"60","author":"B Hellmich","year":"2021","unstructured":"Hellmich B, Lamprecht P, Spearpoint P, Gotte D, Deichmann A, Buchholz I, Schonermark MP, Rutherford P (2021) New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study. Rheumatology (Oxford) 60(10):4868\u20134873. https:\/\/doi.org\/10.1093\/rheumatology\/keaa924","journal-title":"Rheumatology (Oxford)"},{"key":"5508_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01305-2","author":"K Albrecht","year":"2023","unstructured":"Albrecht K, Binder S, Minden K, Poddubnyy D, Regierer AC, Strangfeld A, Callhoff J (2023) Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version. Z Rheumatol. https:\/\/doi.org\/10.1007\/s00393-022-01305-2","journal-title":"Z Rheumatol"},{"issue":"5","key":"5508_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00108-023-01514-0","volume":"64","author":"I Kotter","year":"2023","unstructured":"Kotter I, Krusche M (2023) Inflammatory rheumatic diseases in migrants. Inn Med (Heidelb) 64(5):426\u2013434. https:\/\/doi.org\/10.1007\/s00108-023-01514-0","journal-title":"Inn Med (Heidelb)"},{"issue":"1","key":"5508_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/BOR.0000000000000343","volume":"29","author":"E Seyahi","year":"2017","unstructured":"Seyahi E (2017) Takayasu arteritis: an update. Curr Opin Rheumatol 29(1):51\u201356. https:\/\/doi.org\/10.1097\/BOR.0000000000000343","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 2","key":"5508_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00393-019-0680-1","volume":"78","author":"K Albrecht","year":"2019","unstructured":"Albrecht K, Callhoff J, Zink A (2019) Long-term trends in rheumatology care\u202f: achievements and deficits in 25 years of the German national rheumatology database. Z Rheumatol 78(Suppl 2):65\u201372. https:\/\/doi.org\/10.1007\/s00393-019-0680-1","journal-title":"Z Rheumatol"},{"key":"5508_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002342","author":"K Thiele","year":"2022","unstructured":"Thiele K, Albrecht K, Zink A, Aringer M, Karberg K, Spathling-Mestekemper S, von Hinuber U, Callhoff J (2022) Is the rheumatoid arthritis impact of disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002342","journal-title":"RMD Open"},{"issue":"7","key":"5508_CR17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/annrheumdis-2017-212629","volume":"77","author":"I Redeker","year":"2018","unstructured":"Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D (2018) Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Ann Rheum Dis 77(7):1017\u20131024. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212629","journal-title":"Ann Rheum Dis"},{"key":"5508_CR18","unstructured":"Statistisches Bundesamt d (2023) Erwerbst\u00e4tigenquoten 1991 bis 2022. httphttps:\/\/www.destatis.de\/DE\/Themen\/Arbeit\/Arbeitsmarkt\/Erwerbstaetigkeit\/Tabellen\/erwerbstaetigenquoten-gebietsstand-geschlecht-altergruppe-mikrozensus.html. Accessed 26 Apr 2023."},{"key":"5508_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224571","author":"K Gisslander","year":"2023","unstructured":"Gisslander K, Rutherford M, Aslett L, Basu N, Dradin F, Hederman L, Hruskova Z, Kardaoui H, Lamprecht P, Licholai S, Musial J, O\u2019Sullivan D, Puechal X, Scott J, Segelmark M, Straka R, Terrier B, Tesar V, Tesi M, Vaglio A, Wandrei D, White A, Wojcik K, Yaman B, Little MA, Mohammad AJ, consortium F (2023) Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2023-224571","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5508_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/art.41529","volume":"73","author":"R Goel","year":"2021","unstructured":"Goel R, Chandan JS, Thayakaran R, Adderley NJ, Nirantharakumar K, Harper L (2021) Cardiovascular and renal morbidity in Takayasu arteritis: a population-based retrospective cohort study from the United Kingdom. Arthritis Rheumatol 73(3):504\u2013511. https:\/\/doi.org\/10.1002\/art.41529","journal-title":"Arthritis Rheumatol"},{"key":"5508_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223895","author":"S Monti","year":"2023","unstructured":"Monti S, Milanesi A, Klersy C, Tomelleri A, Dagna L, Campochiaro C, Farina N, Muratore F, Galli E, Marvisi C, Bond M, Berti A, Bortolotti R, Padoan R, Schiavon F, Felicetti M, Nannini C, Cantini F, Giollo A, Rossini M, Conticini E, Frediani B, Conti F, Priori R, Sebastiani M, Cassone G, Quartuccio L, Treppo E, Bettio S, Hoxha A, Lovisotto M, Emmi G, Mattioli I, Leccese P, Caporali R, Argolini LM, Foti R, Visalli E, Colaci M, Salvarani C, Montecucco C, Italian Society of Rheumatology Vasculitis Study G (2023) Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2023-223895","journal-title":"Ann Rheum Dis"},{"key":"5508_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102882","volume":"132","author":"YG Jo","year":"2022","unstructured":"Jo YG, Ortiz-Fernandez L, Coit P, Yilmaz V, Yentur SP, Alibaz-Oner F, Aksu K, Erken E, Duzgun N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Kisacik B, Kotter I, Henes J, Cinar M, Schaefer A, Nohutcu RM, Takeuchi F, Harihara S, Kaburaki T, Messedi M, Song YW, Kasifoglu T, Martin J, Gonzalez Escribano MF, Saruhan-Direskeneli G, Direskeneli H, Sawalha AH (2022) Sex-specific analysis in Behcet\u2019s disease reveals higher genetic risk in male patients. J Autoimmun 132:102882. https:\/\/doi.org\/10.1016\/j.jaut.2022.102882","journal-title":"J Autoimmun"},{"key":"5508_CR23","doi-asserted-by":"publisher","first-page":"1107148","DOI":"10.3389\/fmed.2023.1107148","volume":"10","author":"M Rohde","year":"2023","unstructured":"Rohde M, Kernder A, Acar H, Dusing C, Fischer-Betz R, Haase I, Mucke J, Sander O, Richter J, Filla T, Schneider M, Chehab G (2023) Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis. Front Med (Lausanne) 10:1107148. https:\/\/doi.org\/10.3389\/fmed.2023.1107148","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"5508_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"JU Holle","year":"2011","unstructured":"Holle JU, Gross WL, Latza U, Nolle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E (2011) Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63(1):257\u2013266. https:\/\/doi.org\/10.1002\/art.27763","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5508_CR25","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.40313","volume":"69","author":"A Berti","year":"2017","unstructured":"Berti A, Cornec D, Crowson CS, Specks U, Matteson EL (2017) The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study. Arthritis Rheumatol 69(12):2338\u20132350. https:\/\/doi.org\/10.1002\/art.40313","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5508_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31138\/mjr.34.1.53","volume":"34","author":"A Sadeghi","year":"2023","unstructured":"Sadeghi A, Rostami M, Amraei G, Davatchi F, Shahram F, Karimi Moghaddam A, Karimi Moghaddam Z, Zeraatchi A (2023) Clinical manifestations of Behcet\u2019s disease: a retrospective cross-sectional study. Mediterr J Rheumatol 34(1):53\u201360. https:\/\/doi.org\/10.31138\/mjr.34.1.53","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"5508_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79(1):19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672","journal-title":"Ann Rheum Dis"},{"key":"5508_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","author":"B Hellmich","year":"2023","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"5508_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002235","author":"G Hatemi","year":"2022","unstructured":"Hatemi G, Mahr A, Takeno M, Kim D, Melikoglu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y (2022) Impact of apremilast on quality of life in Behcet\u2019s syndrome: analysis of the phase 3 RELIEF study. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002235","journal-title":"RMD Open"},{"issue":"6","key":"5508_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, Matthis C, Metzler C, Nolle B, Richardt G, Gross WL (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72(6):1011\u20131017. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201531","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5508_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/kev286","volume":"55","author":"JH Schirmer","year":"2016","unstructured":"Schirmer JH, Wright MN, Vonthein R, Herrmann K, Nolle B, Both M, Henes FO, Arlt A, Gross WL, Schinke S, Reinhold-Keller E, Moosig F, Holle JU (2016) Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford) 55(1):71\u201379. https:\/\/doi.org\/10.1093\/rheumatology\/kev286","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5508_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41927-021-00206-2","volume":"5","author":"C Iking-Konert","year":"2021","unstructured":"Iking-Konert C, Wallmeier P, Arnold S, Adler S, de Groot K, Hellmich B, Hoyer BF, Holl-Ulrich K, Ihorst G, Kaufmann M, Kotter I, Muller-Ladner U, Magnus T, Rech J, Schubach F, Schulze-Koops H, Venhoff N, Wiech T, Villiger P, Lamprecht P (2021) The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis. BMC Rheumatol 5(1):40. https:\/\/doi.org\/10.1186\/s41927-021-00206-2","journal-title":"BMC Rheumatol"},{"key":"5508_CR33","unstructured":"Wallmeier Pass F et al. (2022) Das Gemeinsame Vaskulitis-Register im deutschsprachigen Raum (GeVas) \u2013 eine Subgruppenanalyse der 131 RZA-Patienten. Paper presented at the DGRh Berlin"},{"issue":"6","key":"5508_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/acr.20132","volume":"62","author":"JL Barton","year":"2010","unstructured":"Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D (2010) Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62(6):857\u2013864. https:\/\/doi.org\/10.1002\/acr.20132","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"5508_CR35","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/acr.22237","volume":"66","author":"I Castrejon","year":"2014","unstructured":"Castrejon I, Yazici Y, Samuels J, Luta G, Pincus T (2014) Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken) 66(6):934\u2013942. https:\/\/doi.org\/10.1002\/acr.22237","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"5508_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00296-023-05288-4","volume":"43","author":"JJ Hurtado-Arias","year":"2023","unstructured":"Hurtado-Arias JJ, Ramirez-Mulhern I, Gonzalez-Martinez C, Merayo-Chalico J, Barrera-Vargas A, Hinojosa-Azaola A (2023) Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between patients\u2019 and physicians\u2019 perspectives. Rheumatol Int 43(5):933\u2013940. https:\/\/doi.org\/10.1007\/s00296-023-05288-4","journal-title":"Rheumatol Int"},{"issue":"9","key":"5508_CR37","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3899\/jrheum.181072","volume":"46","author":"SZ Aydin","year":"2019","unstructured":"Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Gul A, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tomasson G, Tugwell P, Direskeneli H, Merkel PA (2019) Update on outcome measure development in large-vessel vasculitis: report from OMERACT 2018. J Rheumatol 46(9):1198\u20131201. https:\/\/doi.org\/10.3899\/jrheum.181072","journal-title":"J Rheumatol"},{"key":"5508_CR38","unstructured":"Thiele K, Albrecht K, Kopplin N, Callhoff J (2022) Deutsches Rheuma Forschungszentrum (DRFZ) Programmbereich Epidemiologie und Versorgungsforschung. Standardpr\u00e4sentation 2020, Daten aus der Kerndokumentation. https:\/\/refubium.fu-berlin.de\/handle\/fub188\/36566, Zugriff am 21 June 2023."},{"issue":"1","key":"5508_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00296-021-05000-4","volume":"42","author":"SJ Saur","year":"2022","unstructured":"Saur SJ, Schlogl A, Schmalen T, Krittian S, Pecher AC, Henes M, Xenitidis T, Henes J (2022) Sexual dysfunction and depression in Behcet\u2019s disease in comparison to healthy controls. Rheumatol Int 42(1):121\u2013126. https:\/\/doi.org\/10.1007\/s00296-021-05000-4","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05508-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05508-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05508-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:03:29Z","timestamp":1707933809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05508-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5508"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05508-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JR, KT and KA declared none. JH has received speaker fees from Abbvie, Amgen, Chugai\/Roche, Janssen, Novartis and UCB. JC has received speaker fees from Janssen, Pfizer and Idorsia. UK has received grant and research support and consultancy fees from AbbVie, Amgen, Biocad, Biogen, Chugai, Eli Lilly, Fresenius, Gilead, Gr\u00fcnenthal, GSK, Janssen, MSD, Novartis, Pfizer, Roche and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}